StockNews.AI
GELS
StockNews.AI
1 min

Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner

1. Gelteq initiates commercialization in the U.S. with Healthy Extracts. 2. Healthy Extracts' products are the first utilizing Gelteq's gel technology. 3. The partnership underscores growth potential in U.S. wellness markets. 4. Innovative gel-based solutions cater to consumer demand efficiently. 5. Gelteq's technology may lead to further partnerships in the U.S.

5m saved
Insight
Article

FAQ

Why Bullish?

Gelteq’s entry into the U.S. market indicates successful commercialization efforts. Similar prior instances have led to stock price increases due to market expansion.

How important is it?

The commercialization of Gelteq's technology addresses significant market needs and indicates future profitability, affecting stock price positively.

Why Long Term?

The partnership with Healthy Extracts lays groundwork for sustained growth. Over time, this could lead to recurring revenue streams and enhanced market visibility.

Related Companies

HYEX
MELBOURNE, Australia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company,” NASDAQ: GELS), a clinical and science-based developer of gel-based oral delivery solutions, welcomes the recently announced product launches of Healthy Extracts, Inc. (“Healthy Extracts,” OTCQB: HYEX), whose products apply Gelteq’s proprietary gel technology, into the U.S. nutraceutical market. The Healthy Extracts products are the first to reach Gelteq’s U.S. warehousing facility using Gelteq’s delivery platform, an important milestone that marks Gelteq’s transition from R&D to active commercialization in the U.S. This development highlights both the growth potential of Gelteq’s technology in large-scale wellness markets in the U.S. and its ability to meet consumer demand for innovative, convenient, and clinically-informed formats. “We are pleased to see Gelteq’s technology expand into the U.S. market through our collaboration with Healthy Extracts,” said Nathan Givoni, CEO of Gelteq. “Healthy Extract’s launch demonstrates how our gels can be adapted to create differentiated, consumer-friendly solutions, while paving the way for additional products and partnerships across the U.S. market.” The collaboration with Healthy Extracts, first announced earlier this year, began with warehousing and fulfilment arrangements which laid the foundation for Gelteq's entry into the U.S. market. With this launch, the partnership with Healthy Extract has advanced into active sales and distribution, underscoring the growing momentum behind Gelteq’s gel delivery system and the potential for additional partnership opportunities in the U.S. About Gelteq Ltd. Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a clinical and science-based company dedicated to developing and commercialising gel-based oral delivery solutions for prescription drugs, nutraceuticals, pet care, sports nutrition, and other applications. Gelteq’s proprietary formulation technology aims to address challenges associated with conventional drug delivery, including taste masking, swallowing difficulties, and precision dosing. For more information, visit www.gelteq.com. Gelteq Contact:Investor RelationsMatt Kreps, Darrow Associates IR+1-214-597-8200mkreps@darrowir.com Forward-Looking Statements Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained herein are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied in such statements. For a discussion of these risks and uncertainties, refer to Gelteq’s filings with the U.S. Securities and Exchange Commission (“SEC”), including its Annual Report on Form 20-F filed on November 15, 2024 and its Registration Statement on Form F-1 initially filed with the SEC on July 1, 2025. Gelteq undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Related News